Back to NIFTY PHARMA Details
NIFTY PHARMA Index PE Ratio
41.15
Market Cap Weighted Average Price-to-Earnings Ratio
20
Total Companies
20
With PE Data
41.15
Market Cap Weighted PE
20
Companies with PE Data
12
Historical Data Points
PE Ratio Distribution
0-15 (Low)
1
Companies
15-25 (Moderate)
5
Companies
25-50 (High)
9
Companies
50+ (Very High)
5
Companies
Historical PE Ratio Trends (6 Years)
Component Stocks PE Analysis
| Company | Sector | Market Cap | EPS | PE Ratio |
|---|---|---|---|---|
|
SUNPHARMA
Sun Pharmaceutical
|
Healthcare | ₹4.3 Lakh Cr | ₹45.60 | 39.3 |
|
DIVISLAB
Divis Laboratories
|
Healthcare | ₹1.6 Lakh Cr | ₹82.53 | 64.4 |
|
TORNTPHARM
Torrent Pharmaceuticals
|
Healthcare | ₹1.4 Lakh Cr | ₹56.47 | 64.0 |
|
LUPIN
Lupin
|
Healthcare | ₹1.1 Lakh Cr | ₹71.95 | 22.8 |
|
DRREDDY
Dr Reddys Laboratories
|
Healthcare | ₹1.1 Lakh Cr | ₹67.89 | 19.7 |
|
CIPLA
Cipla
|
Healthcare | ₹1.0 Lakh Cr | ₹65.29 | 21.7 |
|
ZYDUSLIFE
Zydus Life Science
|
Healthcare | ₹90.2K Cr | ₹44.97 | 18.1 |
|
MANKIND
Mankind Pharma
|
Healthcare | ₹84.2K Cr | ₹49.28 | 46.3 |
|
AUROPHARMA
Aurobindo Pharma
|
Healthcare | ₹76.3K Cr | ₹59.81 | 21.8 |
|
ALKEM
Alkem Laboratories
|
Healthcare | ₹63.9K Cr | ₹181.11 | 26.8 |
|
GLENMARK
Glenmark Pharmaceuticals
|
Healthcare | ₹61.3K Cr | ₹37.11 | 57.5 |
|
BIOCON
Biocon
|
Healthcare | ₹57.1K Cr | ₹8.46 | 94.1 |
|
ABBOTINDIA
Abbott
|
Healthcare | ₹55.5K Cr | ₹665.62 | 36.8 |
|
LAURUSLABS
Laurus Labs
|
Healthcare | ₹54.5K Cr | ₹6.65 | 65.8 |
|
IPCALAB
IPCA Laboratories
|
Healthcare | ₹39.8K Cr | ₹29.08 | 41.4 |
|
AJANTPHARM
Ajanta Pharma
|
Healthcare | ₹35.1K Cr | ₹73.56 | 35.5 |
|
JBCHEPHARM
J B Chemicals and Pharmaceuticals
|
Healthcare | ₹32.2K Cr | ₹42.45 | 44.4 |
|
GLAND
Gland Pharma
|
Healthcare | ₹28.2K Cr | ₹42.40 | 32.5 |
|
NATCOPHARM
Natco Pharma
|
Healthcare | ₹18.4K Cr | ₹105.26 | 11.5 |
|
GRANULES
Granules
|
Healthcare | ₹15.2K Cr | ₹20.69 | 28.0 |
Track NIFTY PHARMA PE Analysis in Your Trading Journal
Use this PE ratio analysis to evaluate index valuation and make informed trading decisions. Monitor how PE trends affect your position sizing and market timing strategies.
Add NIFTY PHARMA Trade to JournalRelated Pages for NIFTY PHARMA
Additional stock information and data for NIFTY PHARMA